Alexandria Capital’s AbbVie ABBV Stock Holding History

Alexandria Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	$904K	Sell	8,381 -8	-0.1%	-$863	0.08%	151
2021 Q2	$945K	Buy	8,389 +112	+1%	+$12.6K	0.09%	148
2021 Q1	$896K	Sell	8,277 -274	-3%	-$29.7K	0.09%	149
2020 Q4	$916K	Buy	8,551 +808	+10%	+$86.6K	0.1%	148
2020 Q3	$643K	Sell	7,743 -6	-0.1%	-$498	0.08%	164
2020 Q2	$761K	Buy	7,749 +768	+11%	+$75.4K	0.1%	146
2020 Q1	$532K	Sell	6,981 -93	-1%	-$7.09K	0.09%	157
2019 Q4	$626K	Buy	7,074 +5	+0.1%	+$442	0.08%	160
2019 Q3	$535K	Sell	7,069 -142	-2%	-$10.7K	0.08%	165
2019 Q2	$524K	Sell	7,211 -750	-9%	-$54.5K	0.07%	180
2019 Q1	$642K	Sell	7,961 -50	-0.6%	-$4.03K	0.09%	161
2018 Q4	$739K	Buy	8,011 +712	+10%	+$65.7K	0.12%	151
2018 Q3	$690K	Sell	7,299 -25	-0.3%	-$2.36K	0.1%	150
2018 Q2	$679K	Sell	7,324 -195	-3%	-$18.1K	0.1%	155
2018 Q1	$712K	Sell	7,519 -55	-0.7%	-$5.21K	0.11%	150
2017 Q4	$733K	Buy	7,574 +2,850	+60%	+$276K	0.11%	152
2017 Q3	$420K	Hold	4,724	–	–	0.11%	105
2017 Q2	$343K	Hold	4,724	–	–	0.09%	112
2017 Q1	$308K	Buy	4,724 +57	+1%	+$3.72K	0.08%	115
2016 Q4	$292K	Sell	4,667 -867	-16%	-$54.2K	0.07%	113
2016 Q3	$349K	Buy	5,534 +991	+22%	+$62.5K	0.06%	111
2016 Q2	$281K	Buy	4,543 +14	+0.3%	+$866	0.05%	126
2016 Q1	$259K	Buy	4,529 +16	+0.4%	+$915	0.05%	131
2015 Q4	$267K	Buy	4,513 +1,412	+46%	+$83.5K	0.07%	127
2015 Q3	$169K	Buy	3,101 +11	+0.4%	+$599	0.04%	147
2015 Q2	$208K	Buy	3,090 +11	+0.4%	+$740	0.05%	140
2015 Q1	$180K	Buy	3,079 +12	+0.4%	+$702	0.06%	107
2014 Q4	$201K	Buy	3,067 +9	+0.3%	+$590	0.08%	106
2014 Q3	$177K	Buy	3,058 +11	+0.4%	+$637	0.08%	112
2014 Q2	$172K	Buy	3,047 +12	+0.4%	+$677	0.07%	113
2014 Q1	$156K	Buy	3,035 +11	+0.4%	+$565	0.07%	116
2013 Q4	$160K	Buy	3,024 +576	+24%	+$30.5K	0.07%	114
2013 Q3	$110K	Buy	2,448 +13	+0.5%	+$584	0.05%	136
2013 Q2	$101K	Buy	+2,435	New	+$101K	0.05%	145